Cardiac Energy Metabolism and Diastolic Dysfunction in PLWH

感染者的心脏能量代谢和舒张功能障碍

基本信息

  • 批准号:
    10479599
  • 负责人:
  • 金额:
    $ 55.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

People living with HIV infection (PLWH) on ART live longer today but the incidence and prevalence of chronic diseases is significantly higher that it is in those without HIV. As many as 50% of PLWH today have been reported to have left ventricular diastolic dysfunction (DD), which is associated with atrial fibrillation, exercise intolerance, and the progression to heart failure with preserved ejection fraction (HFpEF). The responsible mechanisms for DD and its progression in contemporary PLWH populations are poorly understood but our preliminary studies suggest that impaired cardiac energy metabolism may be a central factor linking previously reported risk factors to DD. ATP is absolutely required for the normal myocellular relaxation and considerable pre-clinical data and our pilot clinical studies using 31P magnetic resonance spectroscopy (MRS) suggest an “energetic myopathy” as a basis for the DD in PLWH. In addition, inflammation is increased despite combined ART and viral suppression in PLWH and is known to impair mitochondrial function. We propose here to examine cardiac high energy phosphate metabolism, its causes, and its relationship to left ventricular diastolic dysfunction (DD) and DD progression in PLWH. The central hypothesis is that cardiac mitochondrial energy metabolism is impaired even in well-treated PLWH, and promotes the development and progression of DD in PLWH as well as the consequences of DD including cardiac remodeling and HFpEF assessed with echocardiography, increased circulating heart failure biomarkers, heart failure symptoms and decreased exercise performance. The specific aims are 1) to define the scope and extent of myocardial energetic abnormalities at rest and exercise using 31P MRS/MRI in PLWH, 2) to probe the factors underlying cardiac muscle mitochondrial and energetic abnormalities in PLWH, including those unique to PLWH (ART history and cumulative viral history) and others more common in PLWH (increased inflammation, immune activation, insulin resistance, cardiac fibrosis, and/or higher cardiac muscle lipids by MRI), and 3) to determine the functional consequences of observed cardiac muscle energetic changes in PLWH, particularly the presence and progression of DD. The studies will leverage the expertise, resources, and established PLWH cohorts at Johns Hopkins and collect novel cardiac energetic, diastolic function, quantitative exercise tolerance and biomarker data. The results of these studies will deliver novel understandings of the type and extent of myocardial energetic-mitochondrial abnormalities in PLWH, the factors prevalent in PLWH that are most closely related to impaired cardiac mitochondrial-energetic metabolism, and the functional consequences, most importantly diastolic dysfunction. These studies, characterizing the presence and functional consequences of what appears to be a “mitochondriopathy” of cardiac and skeletal muscle in PLWH promise new avenues to better understand the pathophysiology of DD in PLWH and suggest the selection and design of metabolic strategies to reduce the personal and societal impact of HIV disease-related functional decline in this important and growing population.
如今,接受抗逆转录病毒治疗的艾滋病毒感染者 (PLWH) 的寿命更长,但艾滋病毒的发病率和患病率 患有慢性疾病的人明显高于未感染艾滋病毒的人。如今,多达 50% 的 PLWH 已接受过 据报道患有左心室舒张功能障碍(DD),这与心房颤动、运动有关 不耐受,以及进展为射血分数保留的心力衰竭(HFpEF)。负责人 DD 的机制及其在当代 PLWH 人群中的进展尚不清楚,但我们的研究 初步研究表明,心脏能量代谢受损可能是导致先前症状的一个核心因素。 向 DD 报告了危险因素。 ATP 对于正常的肌细胞松弛是绝对必需的,并且需要大量的 临床前数据和我们使用 31P 磁共振波谱 (MRS) 进行的试点临床研究表明 “能量性肌病”作为 PLWH DD 的基础。此外,尽管联合使用,炎症仍会增加 已知 PLWH 中的 ART 和病毒抑制会损害线粒体功能。我们建议在这里检查 心脏高能磷酸盐代谢、其原因及其与左心室舒张功能障碍的关系 (DD) 和 PLWH 的 DD 进展。中心假设是心脏线粒体能量代谢是 即使在治疗良好的 PLWH 中也会受到损害,并促进 PLWH 中 DD 的发生和进展以及 DD 的后果,包括通过超声心动图评估的心脏重塑和 HFpEF,增加 循环心力衰竭生物标志物、心力衰竭症状和运动能力下降。具体的 目的是 1) 使用 31P 定义静息和运动时心肌能量异常的范围和程度 PLWH 中的 MRS/MRI,2) 探讨心肌线粒体和能量异常的潜在因素 在 PLWH 中,包括 PLWH 特有的情况(ART 史和累积病毒史)和其他更常见的情况 PLWH(炎症增加、免疫激活、胰岛素抵抗、心脏纤维化和/或更高的心脏 通过 MRI 测量肌肉脂质),以及 3)确定观察到的心肌能量的功能后果 PLWH 的变化,特别是 DD 的存在和进展。这些研究将利用专业知识, 资源,并在约翰·霍普金斯大学建立了 PLWH 队列,并收集新的心脏能量、舒张功能 功能、定量运动耐量和生物标志物数据。这些研究结果将带来新颖的 了解 PLWH 心肌能量线粒体异常的类型和程度、影响因素 流行于 PLWH 中,与心脏线粒体能量代谢受损最密切相关,并且 功能后果,最重要的是舒张功能障碍。这些研究描述了存在 以及心肌和骨骼肌“线粒体病”的功能后果 PLWH 承诺提供新的途径来更好地了解 PLWH 中 DD 的病理生理学并提出选择建议 和设计代谢策略,以减少艾滋病毒疾病相关功能对个人和社会的影响 这一重要且不断增长的人口数量的下降。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT G WEISS其他文献

ROBERT G WEISS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT G WEISS', 18)}}的其他基金

Mitochondrial energetics, exercise intolerance and fatigability in older people with HIV
老年艾滋病毒感染者的线粒体能量、运动不耐受和疲劳
  • 批准号:
    10367760
  • 财政年份:
    2019
  • 资助金额:
    $ 55.96万
  • 项目类别:
Mitochondrial energetics, exercise intolerance and fatigability in older people with HIV
老年艾滋病毒感染者的线粒体能量、运动不耐受和疲劳
  • 批准号:
    10380614
  • 财政年份:
    2019
  • 资助金额:
    $ 55.96万
  • 项目类别:
Mitochondrial energetics, exercise intolerance and fatigability in older people with HIV
老年艾滋病毒感染者的线粒体能量、运动不耐受和疲劳
  • 批准号:
    10601219
  • 财政年份:
    2019
  • 资助金额:
    $ 55.96万
  • 项目类别:
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
HIV冠状动脉粥样硬化的炎症发病机制
  • 批准号:
    8992823
  • 财政年份:
    2015
  • 资助金额:
    $ 55.96万
  • 项目类别:
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
HIV冠状动脉粥样硬化的炎症发病机制
  • 批准号:
    9303438
  • 财政年份:
    2015
  • 资助金额:
    $ 55.96万
  • 项目类别:
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
HIV冠状动脉粥样硬化的炎症发病机制
  • 批准号:
    8915889
  • 财政年份:
    2014
  • 资助金额:
    $ 55.96万
  • 项目类别:
Inflammation and Coronary Endothelial Function
炎症与冠状动脉内皮功能
  • 批准号:
    9176025
  • 财政年份:
    2014
  • 资助金额:
    $ 55.96万
  • 项目类别:
Inflammation and Coronary Endothelial Function
炎症与冠状动脉内皮功能
  • 批准号:
    8979715
  • 财政年份:
    2014
  • 资助金额:
    $ 55.96万
  • 项目类别:
Bioenergetics and fatigability in older individuals
老年人的生物能和疲劳性
  • 批准号:
    8712312
  • 财政年份:
    2013
  • 资助金额:
    $ 55.96万
  • 项目类别:
Bioenergetics and fatigability in older individuals
老年人的生物能和疲劳性
  • 批准号:
    8564973
  • 财政年份:
    2013
  • 资助金额:
    $ 55.96万
  • 项目类别:

相似海外基金

EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Continuing Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
  • 批准号:
    23H01186
  • 财政年份:
    2023
  • 资助金额:
    $ 55.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了